UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Protons for pediatric ependymoma: Where are we now?

Neuro-oncology (Charlottesville, Va.), 2022-07, Vol.24 (7), p.1203-1204

2022

Volltextzugriff (PDF)

Laparoscopic Cholecystectomy

JAMA : the journal of the American Medical Association, 2018-05, Vol.319 (17), p.1834

2018

Volltextzugriff (PDF)

P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM]

HemaSphere, 2022-06, Vol.6 (Suppl), p.940-941

2022

Volltextzugriff (PDF)

S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) IN SYMPTOMATIC AND ANEMIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR

HemaSphere, 2022-06, Vol.6, p.96-97

2022

Volltextzugriff (PDF)

Diabetes mellitus and macrovascular complications. An epidemiological perspective

Diabetes care, 1992-09, Vol.15 (9), p.1141-1155

1992

Volltextzugriff (PDF)

Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment

Annals of clinical psychiatry, 1999-12, Vol.11 (4), p.205-215

1999

Volltextzugriff (PDF)

1412P Immune changes after enzalutamide (Enza) is added to androgen-deprivation therapy (ADT) in first-line metastatic castration-resistant prostate cancer (mCRPC)

Annals of oncology, 2022-09, Vol.33, p.S1191

2022

Volltextzugriff (PDF)

S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) IN SYMPTOMATIC AND ANEMIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR

HemaSphere, 2022-06, Vol.6, p.96-97

2022

Volltextzugriff (PDF)

Improved transfusion independence rates for momelotinib versus ruxolitinib in anemic JAKi naïve myelofibrosis patients independent of baseline platelet or transfusion status

JOURNAL OF CLINICAL ONCOLOGY, 2021, Vol.39 (15_suppl), p.e19039-e19039

2021

Volltextzugriff (PDF)

Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program

Diabetes (New York, N.Y.), 1987-06, Vol.36 (6), p.689-692

1987

Volltextzugriff (PDF)

The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study

JAMA : the journal of the American Medical Association, 1988-12, Vol.260 (23), p.3456

1988

Volltextzugriff (PDF)

1207PPhase I trial of CV301 in combination with anti-PD-1 therapy in non-squamous NSCLC

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

PCN19 Beyond a Binary Endpoint: Longitudinal and Individual Symptom Analyses from the Simplify-1 Study Demonstrate Clinically Comparable Symptomatic Benefit of Momelotinib to Ruxolitinib in JAK Inhibitor Naive Myelofibrosis Patients

Value in health, 2021-06, Vol.24, p.S22-S22

2021

Volltextzugriff (PDF)

SO-28 A randomized phase II trial of mFOLFOX6-based standard of care alone or in combination with Ad-CEA vaccine plus avelumab in patients with previously untreated metastatic colorectal cancer

Annals of oncology, 2020-07, Vol.31, p.S227

2020

Volltextzugriff (PDF)

874PA phase I study of Ad5 PSA/MUC-1/brachyury vaccine in patients with metastatic castration resistant prostate cancer (mCRPC)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Abstract 15830: Pharmacological Inhibition of Lysophosphatidic Acid Reduces Inflammation and Enhances Myocardial Recovery After Acute Infarction in Diet-Induced Obese Mice

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

Alcohol and hemorrhagic stroke. The Honolulu Heart Program

JAMA : the journal of the American Medical Association, 1986-05, Vol.255 (17), p.2311

1986

Volltextzugriff (PDF)

Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity

The Journal of clinical investigation, 2022-08, Vol.132 (16), p.1-15

2022

Volltextzugriff (PDF)

Early results of a pancreas cancer learning health network: Canopy Cancer Collective

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.645-645

2024

Volltextzugriff (PDF)

Improved Transfusion Independence Rates for Momelotinib versus Ruxolitinib in Anaemic Jaki Naive Myelofibrosis Patients Independent of Baseline Platelet or Transfusion Status

BRITISH JOURNAL OF HAEMATOLOGY, 2022, Vol.197, p.81

2022

Volltextzugriff (PDF)

The General Surgery Residency Experience

Annals of surgery open, 2022-09, Vol.3 (3), p.e187

2022

Volltextzugriff (PDF)

Surgical outcomes after neoadjuvant ablative dose radiation among patients with borderline resectable and locally advanced pancreas cancer from the multi-institutional phase 2 Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) trial

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.718-718

2023

Volltextzugriff (PDF)

Constitutive [mu]-Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence

Science (American Association for the Advancement of Science), 2013-09, Vol.341 (6152), p.1394

2013

Volltextzugriff (PDF)

Stellar Active Region Evolution - I. Estimated Lifetimes of Chromospheric Active Regions and Active Region Complexes

Solar physics, 1997-03, Vol.171 (1), p.191-209

1997

Volltextzugriff (PDF)

Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates

The Journal of clinical investigation, 2001-08, Vol.108 (3), p.447-455

2001

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

KollektionEZB Free E-Journals

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(176)

Publikationsform

Artikel
(180)
Tagungsberichte
(19)

Sprache

Englisch
(198)
Russisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Protons for pediatric ependymoma: Where are we now?

Laparoscopic Cholecystectomy

P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM]

S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) IN SYMPTOMATIC AND ANEMIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR

Diabetes mellitus and macrovascular complications. An epidemiological perspective

Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment

1412P Immune changes after enzalutamide (Enza) is added to androgen-deprivation therapy (ADT) in first-line metastatic castration-resistant prostate cancer (mCRPC)

S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) IN SYMPTOMATIC AND ANEMIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR

Improved transfusion independence rates for momelotinib versus ruxolitinib in anemic JAKi naïve myelofibrosis patients independent of baseline platelet or transfusion status

Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program

The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study

1207PPhase I trial of CV301 in combination with anti-PD-1 therapy in non-squamous NSCLC

PCN19 Beyond a Binary Endpoint: Longitudinal and Individual Symptom Analyses from the Simplify-1 Study Demonstrate Clinically Comparable Symptomatic Benefit of Momelotinib to Ruxolitinib in JAK Inhibitor Naive Myelofibrosis Patients

SO-28 A randomized phase II trial of mFOLFOX6-based standard of care alone or in combination with Ad-CEA vaccine plus avelumab in patients with previously untreated metastatic colorectal cancer

874PA phase I study of Ad5 PSA/MUC-1/brachyury vaccine in patients with metastatic castration resistant prostate cancer (mCRPC)

Abstract 15830: Pharmacological Inhibition of Lysophosphatidic Acid Reduces Inflammation and Enhances Myocardial Recovery After Acute Infarction in Diet-Induced Obese Mice

Alcohol and hemorrhagic stroke. The Honolulu Heart Program

Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity

Early results of a pancreas cancer learning health network: Canopy Cancer Collective

Improved Transfusion Independence Rates for Momelotinib versus Ruxolitinib in Anaemic Jaki Naive Myelofibrosis Patients Independent of Baseline Platelet or Transfusion Status

The General Surgery Residency Experience

Surgical outcomes after neoadjuvant ablative dose radiation among patients with borderline resectable and locally advanced pancreas cancer from the multi-institutional phase 2 Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) trial

Constitutive [mu]-Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence

Stellar Active Region Evolution - I. Estimated Lifetimes of Chromospheric Active Regions and Active Region Complexes

Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates

Aktive Filter

Suchergebnisse filtern